Refine Your Results

Click below to filter your search results

"Last 6 Months"Undo
"Family Planning or Contraception"Undo

Search Results

Return to List
Results 1–1 of 1
Title Date
1.

Depot Medroxyprogesterone Acetate and Bone Effects

Number 602

(Replaces Committee Opinion Number 415, September 2008)

ABSTRACT: Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable contraceptive that affords privacy and has a convenient dose schedule of four times per year, making it appealing to many users, especially adolescents. Although the use of DMPA is associated with loss of bone mine...

June 2014

PDF Format